Highly tractable, sub-nanomolar non-steroidal glucocorticoid receptor agonists
The discovery of 38E1 as a highly potent non-steroidal glucocorticoid agonist is described. Starting from a non-steroidal glucocorticoid agonist aryl pyrazole derivative, the NFκB agonist activity was optimised in an iterative process from pIC 50 7.5 (for 7), to pIC 50 10.1 (for 38E1). An explanatio...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2009-08, Vol.19 (16), p.4846-4850 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The discovery of
38E1 as a highly potent non-steroidal glucocorticoid agonist is described.
Starting from a non-steroidal glucocorticoid agonist aryl pyrazole derivative, the NFκB agonist activity was optimised in an iterative process from pIC
50 7.5 (for
7), to pIC
50 10.1 (for
38E1). An explanation for the SAR observed based is presented along with a proposed docking of
38E1 into the active site of the glucocorticoid receptor. |
---|---|
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2009.06.020 |